Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.15% Nasdaq Up 0.11%
Streaming
Ticker Tape: On

Geron Corporation (GERN)

-NasdaqGS
2.00 Up 0.00(0.14%) 9:52AM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Prev Close:2.00
Open:2.07
Bid:2.06 x 3100
Ask:2.07 x 1700
1y Target Est:2.00
Beta:2.46
Earnings Date:Apr 28 - May 2 (Est.)
Day's Range:1.97 - 2.12
52wk Range:1.05 - 7.79
Volume:671,290
Avg Vol (3m):6,356,870
Market Cap:314.24M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GERN

Comparison

Symbol% ChgMkt Cap
GERNUp 0.14%314.24M
BMYDown 0.22%83.90B
GSKUp 0.31%132.50B
NVSDown 2.76%203.28B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):244.58
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.25
Quarterly EPS Est (Mar-14) :-0.06
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):-1.75

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback